Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

UTokyo Innovation Platform

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 43
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 32
Rounds per year 7.17
Lead investments 8
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.26
Exits 1
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Medical Device
  • Manufacturing
  • Pharmaceutical
Summary

UTokyo Innovation Platform appeared to be the VC, which was created in 2016. The main department of described VC is located in the Tokyo. The venture was found in Asia in Japan.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the UTokyo Innovation Platform, startups are often financed by Japan Science and Technology Agency, Weathernews, SMBC Venture Capital. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, SBI Investment, Mizuho Capital. In the next rounds fund is usually obtained by SMBC Venture Capital, Joe Hirao, Japan Finance Corporation.

Among the most popular portfolio startups of the fund, we may highlight Synspective Inc., Astroscale, CREWT Medical Systems, Inc.. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as IT Infrastructure, Wearables. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan.

Speaking about the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018. The fund is constantly included in 2-6 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of UTokyo Innovation Platform:
Typical Co-investors
UTokyo Innovation Platform is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after UTokyo Innovation Platform:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Japan
Funds with similar focus located in Japan:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

DEM BioPharma

Biotechnology
Life Science
Pharmaceutical
$70M23 Jun 2022 Cambridge, Massachusetts, United States

Carbon Biosciences

Biotechnology
Product Research
Therapeutics
$38M21 Jun 2022 Lexington, Massachusetts, United States

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$20M01 Mar 2022 Chiyoda, Japan

Axial Biotherapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
$37M13 Oct 2021 Massachusetts, United States

TAGCyx Biotechnologies, Inc.

Biotechnology
$1M07 Jul 2021 Chiyoda, Japan

VividQ

3D Technology
Augmented Reality
Software
Virtual Reality
$15M01 Jul 2021 Cambridge, England, United Kingdom

TELEXISTENCE Inc.

Robotics
$20M16 Jun 2021 Chiyoda, Japan

Heartseed

Health Care
$37M11 Jun 2021 Chiyoda, Japan

Libero Thera

Biopharma
Biotechnology
Life Science
Medical
$4M14 May 2021 Chuo, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent UTokyo Innovation Platform?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: